First licence for therapeutic cloning

Britain's Human Fertilisation and Embryology Authority has granted the first licence to create human embryonic stem cells using cell nuclear transfer – a technique also known as therapeutic cloning.

The licence will be held by Newcastle Centre for Life. Stem cells created under this licence will be used for research purposes only.

This licence allows scientists to create human embryos by inserting the nuclei from human skin or stem cells into human eggs. In the UK, research on human embryos is only permitted for certain purposes. The purpose of this research is to increase knowledge about the development of embryos and enable this knowledge to be applied in developing treatments for serious disease. This research is preliminary, it is not aimed at specific illnesses, but is the foundation for further development in the treatment of serious disease.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mitophagy fuels cancer stem cell growth and survival